HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Researchers make gains in understanding antibiotic resistance

Howard Hughes Medical Institute researchers chiseling away at the problem of antibiotic resistance now have a detailed explanation of how the drugs' main cellular target in bacteria evolves to become resistant to some of these medications.

22 Apr 2005

Discovery may lead to new drugs to prevent sexually transmitted HIV infection

Scientists have long suspected that HIV hijacks immune cells called dendritic cells to infiltrate the immune system. Now UCLA AIDS Institute researchers have shown that blocking HIV's access to a naturally occurring molecule on dendritic cells may cut their ability to smuggle the virus into other immune cells.

21 Apr 2005

Adolescents not receiving health counseling

Fewer than 50 percent of adolescent medical checkups include preventive health counseling, despite the demonstrated effectiveness of doctor-delivered advice in promoting healthy behavior as well as reducing risky behavior in teens.

21 Apr 2005

Global Health Service needed to fight AIDS

A report by the non-partisan Institute of Medicine is calling for the creation of a U.S. Global Health Service comprised of doctors, nurses and other health care workers to help combat HIV/AIDS in the world's hardest hit countries.

20 Apr 2005

Official Indian AIDS figures in dispute

A claim by AIDS expert Richard Feachem, that India now has the most HIV-positive people in the world has been dismissed by the Indian government.

20 Apr 2005

Call for a United States Global Health Service

The federal government should create and fund an umbrella organization called the United States Global Health Service (GHS) to mobilize the nation's best health care professionals and other experts to help combat HIV/AIDS in hard-hit African, Caribbean, and Southeast Asian countries, says a new report from the Institute of Medicine of the National Academies.

19 Apr 2005

Experimental vaccine targeting West Nile virus

A small trial testing the safety of an experimental vaccine targeting West Nile virus (WNV) opened today at the National Institutes of Health's (NIH) Clinical Center in Bethesda, MD.

19 Apr 2005

Key discovery about non-Hodgkin lymphoma

There is a surprise benefit to being either an only child, the oldest sibling or even enduring some allergies – you are significantly less likely to develop non-Hodgkin lymphoma (NHL), according to new research from the University of New South Wales (UNSW).

19 Apr 2005

Scientists have discovered the mechanism that enables some CD4 T cells - the main target of HIV - to thwart the virus

The discovery, reported on April 13 in the online version of Nature, could open the door to an entirely new strategy for preventing the spread of HIV infection in the body's cells, according to the senior author of the study, Gladstone Institute of Virology and Immunology Director Warner C. Greene, MD, PhD.

13 Apr 2005

Rates of cervical cancer could jump fourfold to a million a year by 2050

Deaths from cervical cancer could jump fourfold to a million a year by 2050, mainly in developing countries. This could be prevented by soon-to-be-approved vaccines against the virus that causes most cases of cervical cancer- but there are signs that opposition to the vaccines might lead to many preventable deaths. The trouble is that the human papilloma virus (HPV) is sexually transmitted.

13 Apr 2005

Praise for Clinton Foundation plan for children with AIDS

UNICEF has praised a Clinton Foundation plan that will significantly increase the number of children receiving life-prolonging antiretroviral (ARV) drugs specifically formulated for them.

12 Apr 2005

New medical uses for the Kunjin virus

Queensland Government scientists at the Department of Health Services have collaborated with scientists at the University of Queensland (UQ) and The Queensland Institute of Medical Research (QIMR) to discover new medical uses for the Kunjin virus.

12 Apr 2005

Findings from perinatal HIV prevention study in Uganda are valid

A Ugandan drug trial's findings that the AIDS medication nevirapine is effective and safe in preventing HIV transmission from mother to unborn child during birth were well-supported, according to a new, independent analysis by the Institute of Medicine of the National Academies.

12 Apr 2005

Pharmacies to sell syringes without a prescription

Beginning Tuesday, April 12th, pharmacists in San Francisco will be able to sell sterile syringes without a prescription when legislation passed by the Board of Supervisors and signed by Mayor Newsom last month goes into effect.

12 Apr 2005

Framework agreement creates safe blood for China

In an important step to help combat the spread of HIV/AIDS in China, The People's Republic of China's Ministry of Health signed a groundbreaking framework agreement with Washington, D.C.-based Safe Blood International Foundation (Safe Blood International), an organization dedicated to providing a safe blood supply for developing countries to help them stop the spread of HIV/AIDS and other blood-borne diseases at the Ministry of Health in Beijing.

12 Apr 2005

$10 million from Bill Clinton to fight AIDS

Former U.S. President Bill Clinton announced this week that his foundation will donate $10 million towards treatment for children with AIDS in the developing world.

11 Apr 2005

HIV treatment-experienced patients set high standards for therapy success

Patients who have previously failed at least two anti-HIV regimens continue to have high standards for their treatment success, according to a survey commissioned by the American Foundation for AIDS Research (amfAR).

11 Apr 2005

HIVNET 012 perinatal HIV prevention trial praised by IOM

The Institute of Medicine (IOM) of the National Academies of Sciences in the autumn of 2004 was asked by the NIH to review the HIVNET 012 perinatal HIV prevention trial and provide an assessment of the validity of the study results.

10 Apr 2005

Panel in US disputes drug trial allegations

Medical experts have been forced to defend a study conducted in Uganda and called HIVNET 012 that led to the widespread use of a single AIDS drug called nevirapine to protect newborns, after allegations by Dr. Jonathan Fishbein, a National Institutes of Health researcher, that the research was flawed and the conclusions were unfounded.

10 Apr 2005

Test of new HIV drug

A study under way at UAB aims to determine whether the first of a new class of HIV drugs is safe and effective in preventing the virus from entering healthy cells.

10 Apr 2005